2 stocks that rewarded patient investors handsomely over the years

Use some advice from Warren Buffett to grow your investments.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In a recent interview, Berkshire Hathaway Inc. (NYSE: BRK.A, BRK.B) chairman and CEO Warren Buffett talked on a number of ideas that should guide investors' thinking on individual wealth. The 83-year-old investor is worth around US$60 billion, so he knows what he is talking about.

One thing is we shouldn't feel bad when stocks go down. If your stock is a quality stock, and growing as you expected, you may want to see it dip down to buy more at a discount.

Next, you don't need to be an expert in many companies to know which investments are good. He said you just need some conviction that a company is "…likely to make more money five or 10 or 20 years from now than they're earning now."

Thirdly, don't chase after quick profits. He stresses thinking of yourself as the owner of the whole company, not just a stock. If you had a successful business, you wouldn't sell it. You'd want to grow it even more.

Looking for a quick profit may be ok for some. However, they will miss out on fantastic companies that could double in share price many times over the years.

Here are two stocks that are examples of this sage advice.

REA Group Limited (ASX: REA), the owner of realestate.com.au, has risen in share price over 60 times since 2004. During the GFC, it fell from about $7 to as low as $3.

For those who sold out or didn't buy in at that time, they missed a great opportunity as it recovered and climbed to its current $49.00.

Many people who used the website for property searches could have seen the popularity of it without being financial experts. The annual reports would have informed them of the rising earnings.

CSL Limited (ASX: CSL), the biopharmaceutical company, develops medical products for blood disorders and viral and bacterial diseases. Patient investors over the past 10 years saw the share price rise seven times.

During 2008 and 2011, the share priced traded mostly in a $30-$40 range. Since then it has gone up to $71.70 due to growing earnings. Investors could have seen the increasing revenues and high profit margins year by year, and realised it was a winning company even if they didn't have a medical background.

Foolish takeaway

If the stock stories of these companies stay the same or improve, and they keep growing earnings, they have the opportunity to advance in price.

Occasionally, individual companies can stumble, or the stock market can have a big correction. Lower share prices could turn out to be a chance to buy your favourite stocks at a discount.

Motley Fool contributor Darryl Daté-Shappard does not own shares in any company mentioned. 

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »